Discontinuation of Car Seat Tolerance Screening and Postdischarge Adverse Outcomes in Infants Born Preterm

David Braun1, Joseph W Kaempf2, Ngoc J Ho3

  • 1Department of Neonatal-Perinatal Medicine, Southern California Permanente Medical Group, Pasadena, CA; Department of Research and Evaluation, Southern California Permanente Medical Group, Pasadena, CA.

PubMed

Insights

Discontinuing car seat tolerance screening (CSTS) for preterm infants did not increase 30-day postdischarge adverse outcomes. Further evaluation is needed to determine the value of CSTS as a standard assessment.

Area of Science:

  • Neonatology
  • Pediatric Health Outcomes
  • Health Services Research

Background:

  • Car seat tolerance screening (CSTS) is a predischarge assessment for preterm infants.
  • The clinical utility and impact of discontinuing CSTS on infant safety after discharge require investigation.

Purpose of the Study:

  • To examine the association between discontinuing predischarge car seat tolerance screening (CSTS) and 30-day postdischarge adverse outcomes in preterm infants.

Main Methods:

  • A retrospective cohort study was conducted in a 14-hospital integrated health care system.
  • Infants born preterm between 2010-2021 were analyzed, comparing outcomes during periods with and without CSTS.
  • The primary outcome was a composite of death, 911 call-triggered transports, or readmissions for specific respiratory and cardiorespiratory events within 30 days of discharge.

Main Results:

  • The unadjusted primary outcome rate was 1.02% with CSTS and 1.06% after discontinuation (P=.76).
  • Adjusted odds ratio was 0.95 (95% CI: 0.75-1.19), indicating no significant difference.
  • No statistically significant differences were observed in outcome components, gestational age strata, or NICU admission status.

Conclusions:

  • Discontinuation of CSTS in a large health care network was not linked to increased 30-day postdischarge adverse events in preterm infants.
  • The findings suggest that CSTS may not be essential for all preterm infants before discharge.
  • Further research is warranted to evaluate the ongoing value of CSTS as a standard predischarge assessment.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
786
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
908
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
354